Based on demographic and surgical characteristics from hundreds of patients, we calculate a clinical score to determine if chemotherapy would be beneficial for you in treating Stage IA UPSC.
The results come from a machine learning model based on NCDB data of 1,751 patients between the years 2010 to 2014. The 5-year survival rates and risk categories mentioned below are based on these patients.
The calculator produces a score based on the answers to the questions below.
A score less than 11 means that a patient falls into the "low risk" category. For low risk patients in the study, chemotherapy increases the 5-year survival from 84% to 87%.
Patients who score between 11 and 16 fall into the "moderate risk" category and may benefit from chemotherapy. For moderate risk patients in the study, chemotherapy increases the 5-year survival from 66% to 79%.
Patients who score 16 or higher are in the "high risk" group and may benefit from chemotherapy. For high risk patients in the study, chemotherapy increases the 5-year survival from 42% to 64%.
DISCLAIMER: this risk calculator estimates the chance of a favorable outcome from chemotherapy. This chance is calculated based on information provided below and data from a large number of patients with similar information. Please note the chance of a favorable outcome is only an estimate and there may be other important factors not included in the calculator. Results are not guaranteed. Please consult a doctor about these results. Jinfiniti is not responsible for medical decisions made based on the results of this calculator.